Caprock Group LLC Makes New $282,000 Investment in The Cooper Companies, Inc. (NASDAQ:COO)

Caprock Group LLC acquired a new position in The Cooper Companies, Inc. (NASDAQ:COO) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 3,067 shares of the medical device company’s stock, valued at approximately $282,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of COO. Victory Capital Management Inc. grew its holdings in Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after purchasing an additional 737,726 shares during the period. Franklin Resources Inc. increased its position in shares of Cooper Companies by 194.0% in the third quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company’s stock valued at $5,265,000 after acquiring an additional 32,260 shares during the last quarter. Principal Financial Group Inc. increased its position in shares of Cooper Companies by 6.6% during the 3rd quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock worth $26,295,000 after purchasing an additional 14,687 shares during the last quarter. Highland Capital Management LLC bought a new stake in shares of Cooper Companies during the 4th quarter worth approximately $4,004,000. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Cooper Companies by 13.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after buying an additional 573,908 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Cooper Companies stock opened at $95.29 on Friday. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38. The firm has a market capitalization of $19.02 billion, a PE ratio of 48.87, a price-to-earnings-growth ratio of 2.45 and a beta of 1.00. The firm’s 50 day simple moving average is $95.21 and its 200 day simple moving average is $99.72.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter in the previous year, the company posted $0.87 EPS. Cooper Companies’s quarterly revenue was up 9.8% compared to the same quarter last year. As a group, analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the subject of a number of recent analyst reports. Morgan Stanley cut their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Citigroup dropped their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Finally, Wells Fargo & Company upped their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Cooper Companies has an average rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.